Motivating Latino Caregivers of Children With Asthma to Quit Smoking: A Randomized Trial

Centers for Behavioral and Preventive Medicine, The Warren Alpert Medical School of Brown University, Coro Building-West, One Hoppin Street, Suite 500, Providence, RI 02903, USA.
Journal of Consulting and Clinical Psychology (Impact Factor: 4.85). 02/2010; 78(1):34-43. DOI: 10.1037/a0016932
Source: PubMed


Secondhand smoke exposure is associated with asthma onset and exacerbation. Latino children have higher rates of asthma morbidity than other groups. The current study compared the effectiveness of a newly developed smoking cessation treatment with existing clinical guidelines for smoking cessation.
Latino caregivers who smoked (N = 133; 72.9% female; mean age = 36.8 years) and had a child with asthma were randomly assigned to receive 1 of 2 smoking cessation counseling interventions during a home-based asthma program: (a) behavioral action model (BAM; modeled on clinical guidelines for smoking cessation) or (b) precaution adoption model (PAM; feedback on the caregiver's carbon monoxide level and child's secondhand smoke exposure using Motivational Interviewing). Counseling was delivered by a bilingual Latina health educator, and the content was tailored to Latino values and culture. It was not necessary for smokers to want to quit smoking to participate. Smoking cessation was biochemically verified and secondhand smoke exposure was objectively measured through passive nicotine monitors.
Intent-to-treat analyses showed that 20.5% of participants in the PAM condition and 9.1% of those in the BAM condition were continuously abstinent at 2 months posttreatment (OR = 2.54; 95% CI = 0.91-7.10), whereas 19.1% of participants in the PAM condition and 12.3% of those in BAM condition were continuously abstinent at 3 months posttreatment (OR = 1.68; 95% CI = 0.64-4.37). Secondhand smoke exposure decreased only in the BAM condition (p < .001), an effect due to less smoking around the child among nonquitters in this condition. Asthma morbidity showed significant decreases in the posttreatment period for the PAM group only (p < .001).
Results provide support for targeting specific populations with theory-based interventions.

Download full-text


Available from: Sally Katharine Hammond, Aug 14, 2014
  • Source
    • "Two key research priorities are (a) developing linkages between various channels of smoking cessation delivery and using a theoretical framework to guide this integration (e.g., expanded chronic care model; Barr et al., 2003) and (b) potentiating the effect of these channels through developing de novo theories or applying effective theoretical models from other fields of research to smoking cessation. Three studies in this special section utilize theory-based treatments that have demonstrated effectiveness in other areas of health behavior change and apply them to smoking cessation (Borrelli et al., 2010; Cinciripini et al., 2010; MacPherson et al., 2010). Although these articles report the main effects of treatment on smoking cessation, more research is needed on the mechanisms of change so that intervention targets can be more accurately pinpointed . "
    [Show abstract] [Hide abstract]
    ABSTRACT: The current introductory article provides the rationale for the special section on understudied smokers and innovative treatments. This article proposes a definition of "special populations" of smokers, outlines a priori criteria by which to judge whether an intervention should be adapted for these smokers, and delineates a process by which cultural adaptation of an intervention can be achieved. Next steps for innovative, theory-based treatments with special populations and with general populations of smokers are discussed. Special populations of smokers are defined as having (a) >10% higher smoking prevalence than the general population of smokers, (b) disproportionate tobacco-related health disparities, (c) less access to treatments, and (d) a lack of prospective, longitudinal treatment trials. Cultural adaptation of evidenced-based treatments (EBTs) for underserved smokers should be applied more widely, outside the bounds of race and ethnicity, but also judiciously, following several a priori criteria. Cultural adaptation may be justified if the target population differs from the general population in (a) rates and patterns of smoking, (b) burden of tobacco-related health diseases, (c) predictors of smoking behavior, (d) risk factors for treatment failure, (e) protective factors that facilitate quitting, (f) treatment engagement, (g) treatment response, and (h) perceived social validity of the EBT. Once these criteria are met, four phases of cultural adaptation of an EBT for the target population are proposed. Innovative treatments need to be developed that use novel channels and linkages between channels; test novel theories or build on mechanisms research to more accurately pinpoint targets of change; and increase consumer demand for EBTs. The process of cultural adaptation should be thoughtfully conducted with a priori definitions and criteria as well as standardized processes. Coupled with innovative, theory-based treatments, these considerations could help to jump-start stalled smoking cessation rates.
    Preview · Article · Feb 2010 · Journal of Consulting and Clinical Psychology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Biomedical risk assessment is the process of giving smokers feedback on the physical effects of smoking using physiological measurements (for example: exhaled carbon monoxide measurement or lung function tests). It has been considered as a tool to encourage smokers to quit. This review includes 15 studies. Of them, only two found that biomedical risk assessment significantly increased long term quitting. In one study, smokers who had their lung function tested and the results explained in terms of lung age compared to their actual age were more likely to quit than people given the same test but without the explanation. In another study, light smokers who were shown images of their arteries were more likely to quit than those who were not shown images. Mixed quality evidence does not suggest that other types of biomedical risk assessment increase a smoker's chance of successfully quitting compared with standard treatments.
    Full-text · Article · Feb 2009 · Cochrane database of systematic reviews (Online)
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To identify factors associated with motivation to quit smoking among parents of urban children with asthma. We analyzed data from parents who smoke and had a child enrolled in the School-Based Asthma Therapy (SBAT) trial. We assessed asthma symptoms, children's cotinine, and parent smoking behaviors. Motivation to quit smoking was assessed by a 10-point continuous measure (1, not at all motivated; 10, very motivated). 209 parents smoked (39% of sample), and children's mean cotinine was 2.48 ng/ml. Motivation to quit was on average 6.9, and 47% of parents scored >or=8 on the scale. Parents who believed their child's asthma was not under good control, and parents who strongly agreed their child's asthma symptoms would decrease if they stop smoking had higher motivation to quit compared to their counterparts (p<.05). In a multivariate analysis, parents who believed their child's asthma was not under control had more than twice the odds of reporting high motivation to quit. Parents' perception of the risks of smoking to their child with asthma is associated with motivation to quit. Raising awareness about the effect of smoking and quitting on children's asthma might increase motivation to quit among parents.
    Full-text · Article · Sep 2009 · Patient Education and Counseling
Show more